Related Experiment Videos
Neutrophilic dermatosis complicating lenalidomide therapy
Khanh P Thieu1, Misha Rosenbach, Xiaowei Xu
1Harvard Medical School, Boston, Massachusetts, USA.
Journal of the American Academy of Dermatology
|July 7, 2009
Summary
Lenalidomide therapy for multiple myeloma can cause a rare skin condition called neutrophilic dermatosis. This case report details its presentation on the lower extremities.
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- Lenalidomide, a thalidomide derivative, is an immunomodulatory drug used for multiple myeloma and myelodysplastic syndrome.
- It is also being investigated for metastatic melanoma treatment.
- Lenalidomide enhances T-cell and NK-cell activity and inhibits pro-inflammatory cytokines.
Observation:
- A patient undergoing lenalidomide therapy for multiple myeloma developed a skin condition.
- The condition primarily affected the lower extremities.
- The patient presented with neutrophilic dermatosis.
Findings:
- The case highlights a rare adverse dermatologic reaction to lenalidomide.
- Neutrophilic dermatosis is characterized by inflammation and neutrophil infiltration in the skin.
- This presentation emphasizes the importance of monitoring for skin toxicities during lenalidomide treatment.
Implications:
- This case expands the known spectrum of lenalidomide-induced skin reactions.
- Early recognition and management of neutrophilic dermatosis are crucial for patient well-being.
- Further research may elucidate the mechanisms underlying lenalidomide-associated dermatoses.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...